bne Intellinews
CEE’s leading pharma Richter Gedeon has acquired a "significant stake" and entered into a business development partnership with Granata Bio, a US-based company specialising in reproductive health, CEO Gabor Orban announced at a press conference after the release of the Q1 earnings report on May 13.
As a result of the acquisition, Richter will gain a seat on Granata Bio's board, he added.
The move reflects Richter’s broader ambition to strengthen its Women’s Healthcare (WHC) division and deepen its commercial and strategic presence in the United States, the world’s largest pharmaceutical market.
